First American Trust FSB trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 21.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,900 shares of the healthcare conglomerate’s stock after selling 505 shares during the quarter. First American Trust FSB’s holdings in UnitedHealth Group were worth $961,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors also recently modified their holdings of the stock. Howard Capital Management Group LLC purchased a new position in shares of UnitedHealth Group during the 3rd quarter valued at $341,000. Principal Financial Group Inc. lifted its holdings in UnitedHealth Group by 11.3% during the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock valued at $1,039,933,000 after purchasing an additional 180,479 shares during the last quarter. Algert Global LLC bought a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $1,763,000. Fisher Asset Management LLC boosted its holdings in UnitedHealth Group by 3.5% in the 3rd quarter. Fisher Asset Management LLC now owns 3,197,167 shares of the healthcare conglomerate’s stock worth $1,869,320,000 after buying an additional 107,097 shares during the period. Finally, Bank of Hawaii raised its holdings in UnitedHealth Group by 108.0% during the 3rd quarter. Bank of Hawaii now owns 4,263 shares of the healthcare conglomerate’s stock valued at $2,492,000 after acquiring an additional 2,213 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.
UnitedHealth Group Stock Performance
NYSE UNH opened at $516.94 on Tuesday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a 50-day simple moving average of $509.71 and a two-hundred day simple moving average of $546.15. The firm has a market cap of $472.85 billion, a price-to-earnings ratio of 33.35, a PEG ratio of 1.37 and a beta of 0.62.
UnitedHealth Group Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.62%. UnitedHealth Group’s payout ratio is presently 54.19%.
Insider Buying and Selling at UnitedHealth Group
In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at this link. 0.33% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
A number of analysts recently issued reports on the company. Wells Fargo & Company decreased their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Piper Sandler cut their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Truist Financial decreased their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Finally, Oppenheimer boosted their target price on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $629.32.
Read Our Latest Stock Report on UnitedHealth Group
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- What is a Dividend King?
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Insider Trading – What You Need to Know
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- How to Plot Fibonacci Price Inflection Levels
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.